Daily Briefing

5 minute read

Health policy roundup: RFK Jr. touts AI as savior from 'medical tyranny'


At a Make America Health Again conference, HHS Secretary Robert F. Kennedy Jr. said that AI can provide patients with "a second opinion that is much better informed than any doctor in the country" and could "free us from medical tyranny," in today's roundup of the news in healthcare politics.

RFK Jr. says AI is 'better informed' than doctors

At a Make America Health Again conference, HHS Secretary Robert F. Kennedy Jr. during a "fireside chat" conversation with Vice President JD Vance said that AI can provide patients with "a second opinion that is much better informed than any doctor in the country" and could "free us from medical tyranny."

During the chat at the conference, which was sponsored in part by AI companies like Anthropic and OpenAI, Kennedy wholeheartedly endorsed the use of AI for medical advice.

"One of the things that is going to change is that we're never ever again going to be able to be dominated by public officials who tell us, 'Trust the experts,'" Kennedy said.

"If somebody tells you, 'Masks work, trust the experts,' AI may tell you otherwise," he added. "If somebody tells you, 'Social distancing works, trust the experts,' AI may correct that. And if somebody tells you that a vaccine will prevent transmission and infection, or you need to take it to protect your grandmother, AI may say it actually doesn't do that."

Kennedy also said that OpenAI CEO Sam Altman told him in a recent visit to his office that it would be "malpractice for a doctor to make a diagnosis or to make a prescription without at least checking AI," which Kennedy apparently agreed with.

(Stolberg, New York Times, 9/29)

Trump cancels almost $1B in spending approved by Congress

President Donald Trump last week canceled nearly $1 billion in federal funding approved by Congress, mainly focused on HHS programs serving undocumented immigrants and unaccompanied children.

"These funds previously went to pro-illegal immigration programs and Non-Governmental Organizations that provided services to refugees, asylees, and other non-citizens and put unaccompanied children in harm's way," the White House said in a press release, adding that recent decreases in border crossings meant that funding towards these programs became excessive and warranted their recission.

In total, there were $810 million in cuts. Aside from the cuts to HHS programs, there were cuts to a Department of Education program for migrant students, a Department of Justice office focused on reducing racial tensions, a business development initiative for minority entrepreneurs, and a Housing and Urban Development Department program that provided housing counseling services.

According to the U.S. Government Accountability Office, Trump canceled the funds through a process known as a "pocket recission," which occurs "when a president asks Congress to rescind (or cancel) funds very close to the end of the fiscal year — so close that the funds expire before they can be used for new obligations."

Under the Impoundment Control Act, a presidential administration is allowed to temporarily withhold funding for 45 days while Congress considers a recissions request. If lawmakers choose not to approve the request, the funds must be released. However, a pocket recission occurs when the president sends the request to Congress within 45 days of the end of the fiscal year, essentially pausing the funding until it runs out at the end of the year regardless of congressional action.

Sen. Susan Collins (R-Maine), chair of the Senate Appropriations Committee, said Trump's use of the pocket recission process was "unlawful" and called on the Office of Management and Budget (OMB) to spend all of the $1.3 billion appropriated for fiscal year 2025 as intended.

"This move shows that OMB intentionally withheld these funds for months to execute this unlawful cancellation of appropriations that were approved on a bipartisan basis and signed into law," Collins said in a social media post. "OMB is an agency of the executive branch. It does not get to decide which programs are worth funding."

(Freking/Cooper, Associated Press, 9/25; Bhakta, The Hill, 9/25)

White House backs away from plan to control NIH grants

The Trump administration has backtracked from a plan to draft an executive order establishing a board that would decide which grants NIH should fund, according to people familiar with the situation who spoke to the New York Times.

Initially, people with knowledge of the situation told the Times and POLITICO that President Donald Trump had directed Russ Vought, director of OMB, to draft the order to establish the board, which would have been able to veto grants that didn't align with the Trump administration's political agenda.

However, fierce opposition to the news from both Democrats and Republicans in Congress led the White House to recalibrate, the people told the Times. Senate Appropriations Committee Chair Susan Collins (R-Maine) sent a letter to Vought and NIH Director Jay Bhattacharya warning that a new commission would "undermine" congressional intent and the pursuit of good science.

Sen. Patty Murray (D-Wash.), who is also on the appropriations committee, accused Trump of trying to appoint a "panel of lackeys" whose primary task would be to help the president "settle a score."

While the administration has backed away from the executive order, the sources told the Times that officials don't appear to have completely abandoned their desire to tighten their grip on federal research spending.

(Stolberg/Romm, New York Times, 9/23)

Senate committee advances HHS deputy secretary nomination

The Senate Finance Committee last week advanced the nomination of Chris Klomp to be deputy secretary of HHS, setting him up for a floor vote for confirmation.

The committee voted 15-12 in favor of Klomp, with Sen. Sheldon Whitehouse (D-R.I.) joining the Republicans on the committee.

Klomp is currently a senior advisor to HHS Secretary Robert F. Kennedy Jr. and has led negotiations over "most favored nation" drug pricing deals between the administration and pharmaceutical companies.

"Part of my responsibility is to enable the smooth operations of the department. I’m responsible for personnel, among other things," Klomp said during his confirmation hearings with both the Finance Committee and the Senate Health, Education, Labor, and Pensions Committee. "My job is to make sure that we have everything."

(Weixel, The Hill, 9/24)


SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

INDUSTRY SECTORS

RELATED RESOURCES

Don't miss out on the latest Advisory Board insights

Create your free account to access 1 resource, including the latest research and webinars.

Want access without creating an account?

   

You have 1 free members-only resource remaining this month.

1 free members-only resources remaining

1 free members-only resources remaining

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This content is available through your Curated Research partnership with Advisory Board. Click on ‘view this resource’ to read the full piece

Email ask@advisory.com to learn more

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

This is for members only. Learn more.

Click on ‘Become a Member’ to learn about the benefits of a Full-Access partnership with Advisory Board

Never miss out on the latest innovative health care content tailored to you. 

Benefits Include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.